DUBLIN--(BUSINESS WIRE)--ICON plc, (NASDAQ: ICLR) a world-leading clinical research organisation powered by healthcare intelligence, today releases its ICON Cares 2024 Report. The report outlines how ...
Quarter four revenue was $2,112.5 million. Full year revenue was $8,251 million. Quarter four adjusted EBITDA of $327.1 ...
Stock-based compensation expense represents the amount of recurring expense related to the company’s equity compensation programs (inclusive of employer related taxes). (b) Foreign currency ...
Wall Street expects a year-over-year decline in earnings on lower revenues when Icon PLC (ICLR) reports results for the quarter ended March 2025. While this widely-known consensus outlook is important ...
Icon reported solid fourth-quarter revenue of $1.8 billion and ended the year with total revenue of nearly $5.5 billion, in line with expectations. Icon’s acquisition of PRA Health Sciences, which ...
DUBLIN--(BUSINESS WIRE)--ICON plc, (NASDAQ:ICLR) a world-leading healthcare intelligence and clinical research organisation, today releases its ICON Cares 2023 Report. This outlines how the company is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results